NPPA fixes price for various FDCs having Sitagliptin, Linagliptin Ruchika Sharma7 Feb 2024 6:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...
Torrent Pharma Gets CDSCO Panel Nod To study antidiabetic FDC Empagliflozin plus Sitagliptin Dr. Divya Colin17 Jan 2024 6:00 PM ISTNew Delhi: The drug major Torrent Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Modify eGFR value as per standard guidelines: CDSCO Panel Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin31 Dec 2023 5:15 PM ISTNew Delhi: Reviewing the drug major Hetero Lab's revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin...
Conduct Phase III CT: CDSCO Panel Tells Akum Pharmaceutical on Antidiabetic FDC Dr. Divya Colin10 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the proposal for the clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM Patients Uncontrolled on Existing Therapy Dr. Kamal Kant Kohli2 Dec 2023 11:43 AM ISTAn approach of using a once-daily triple fixed-dose combination of dapagliflozin, sitagliptin, and metformin ER (extended-release) in Indian type 2...
Conduct Phase III clinical trial: CDSCO to Zydus Healthcare over FDC Empagliflozin plus Sitagliptin Dr. Divya Colin12 Nov 2023 4:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Zydus Healthcare, the Subject Expert Committee ( SEC) functional under the Central...
Zydus Lifesciences wins USFDA nod for diabetes drug Zituvimet Ruchika Sharma6 Nov 2023 11:34 AM ISTThe approval of ZITUVIMET is based on research, development, regulatory, and manufacturing work performed by Zydus teams.
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
Zydus Lifesciences bags USFDA approval for type 2 diabetes mellitus drug Zituvio for adults Ruchika Sharma21 Oct 2023 11:19 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA)...
Dr Reddy's Gets CDSCO Panel Nod to Study Antidiabetic FDC Empagliflozin, Sitagliptin, Metformin tablet Dr. Divya Colin20 Oct 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod To Market Sitagliptin, Metformin, Glimepiride FDC in Lower Strength Dr. Divya Colin30 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Synokem Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Sitagliptin plus Empagliflozin Dr. Divya Colin3 Sept 2023 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
